The present invention relates to a process for the preparation of novel pyrrolo [2,1-c][1,4]benzodiazepines useful as potential antitumour agents. This invention also relates to a process for the preparation of new pyrrolo[2,1-c][1,4]benzodiazepines as potential antitumour agents. More particularly, it provides a process for the preparation of 7-methoxy-8-[6′-(4″-fluorophenyl)-2′-methylpyrimidine-4′-yloxy]alkoxy-(11aS)-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1,c][1,4]benzodiazepin-5-one with aliphatic chain length variations for the compounds and it also describes the anticancer (antitumour) activity. The structural formula of novel pyrrolo[2,1-c][1,4]benzodiazepine is as follows.
本发明涉及一种制备新型
吡咯并[2,1-c][1,4]苯二氮平类化合物的方法,该化合物可作为潜在的
抗肿瘤药物。本发明还涉及一种制备新型
吡咯并[2,1-c][1,4]苯二氮平类化合物的方法,该化合物也可作为潜在的
抗肿瘤药物。更具体地说,本发明提供了一种制备7-甲氧基-8-[6′-(4″-
氟苯基)-2′-
甲基嘧啶-4′-氧基]烷氧基-(11aS)-1,2,3,11a-四氢-5H-
吡咯并[2,1-c][1,4]苯二氮平-5-酮的方法,其中化合物的脂肪链长度有所变化,并描述了其抗癌(抗肿瘤)活性。新型
吡咯并[2,1-c][1,4]苯二氮平的结构式如下。